Respiri - Focus on cost optimisation
To support an optimal roll-out of its US commercialisation strategy for its wheezo device, Respiri recently announced several cost-saving...
671 Views
Respiri - Objective measures for better outcomes
Respiri is an Australian medical device and software-as-a-service (SaaS) company, developing a novel remote patient monitoring approach to...
674 Views
Respiri - NIHR funding to seek better outcomes
Respiri has received a £2m grant from the UK National Institute for Health Research (NIHR) to initiate a clinical study (TEAM-care) for wheezo, its...
667 Views